Report Detail

Table of Contents

    Global Cold Chain for Pharmaceutical Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 Cold Storage -Product Introduction and Major Manufacturers
        • 1.1.2 Cold Chain Transport -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Global Cold Chain for Pharmaceutical Market Assessment, by Segmentation

      • 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
      • 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
      • 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)

      3 Regional Market Analysis

      • 3.1 China Cold Chain for Pharmaceutical Market
        • 3.1.1 Top Companies leading Cold Chain for Pharmaceutical Development in China (2017-2021)
        • 3.1.2 Sales Value of Major Company in China Market (2017-2021)
        • 3.1.3 China Cold Chain for Pharmaceutical Price (USD/Unit), by Type (2019-2020)
        • 3.1.4 Sales in China Market, by Type (2026-2027)
      • 3.2 EU Cold Chain for Pharmaceutical Market
        • 3.2.1 Top Companies leading Cold Chain for Pharmaceutical Development in EU (2017-2021)
        • 3.2.2 Sales Value of Major Company in EU Market (2017-2021)
        • 3.2.3 EU Cold Chain for Pharmaceutical Price (USD/Unit), by Type (2019-2020)
        • 3.2.4 Sales in EU Market, by Type (2026-2027)
      • 3.3 USA Cold Chain for Pharmaceutical Market
        • 3.3.1 Top Companies leading Cold Chain for Pharmaceutical Development in USA (2017-2021)
        • 3.3.2 Sales Value of Major Company in USA Market (2017-2021)
        • 3.3.3 USA Cold Chain for Pharmaceutical Price (USD/Unit), by Type (2019-2020)
        • 3.3.4 Sales in USA Market, by Type (2026-2027)
      • 3.4 Japan Cold Chain for Pharmaceutical Market
        • 3.4.1 Top Companies leading Cold Chain for Pharmaceutical Development in Japan (2017-2021)
        • 3.4.2 Sales Value of Major Company in Japan Market (2017-2021)
        • 3.4.3 Japan Cold Chain for Pharmaceutical Price (USD/Unit), by Type (2019-2020)
        • 3.4.4 Sales in Japan Market, by Type (2026-2027)
      • 3.5 India Cold Chain for Pharmaceutical Market
        • 3.5.1 Top Companies leading Cold Chain for Pharmaceutical Development in India (2017-2021)
        • 3.5.2 Sales Value of Major Company in India Market (2017-2021)
        • 3.5.3 India Cold Chain for Pharmaceutical Price (USD/Unit), by Type (2019-2020)
        • 3.5.4 Sales in India Market, by Type (2026-2027)
      • 3.6 Southeast Asia Cold Chain for Pharmaceutical Market
        • 3.6.1 Top Companies leading Cold Chain for Pharmaceutical Development in Southeast Asia (2017-2021)
        • 3.6.2 Sales Value of Major Company in Southeast Asia Market (2017-2021)
        • 3.6.3 Southeast Asia Cold Chain for Pharmaceutical Price (USD/Unit), by Type (2019-2020)
        • 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
      • 3.7 South America Cold Chain for Pharmaceutical Market
        • 3.7.1 Top Companies leading Cold Chain for Pharmaceutical Development in South America (2017-2021)
        • 3.7.2 Sales Value of Major Company in South America Market (2017-2021)
        • 3.7.3 South America Cold Chain for Pharmaceutical Price (USD/Unit), by Type (2019-2020)
        • 3.7.4 Sales in South America Market, by Type (2026-2027)

      4 Value Chain (Impact of COVID-19)

      • 4.1 Cold Chain for Pharmaceutical Value Chain Analysis
        • 4.1.1 Upstream
        • 4.1.2 Downstream
      • 4.2 COVID-19 Impact on Cold Chain for Pharmaceutical Industry
        • 4.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 4.3 Cost-Under the Epidemic Situation
        • 4.3.1 Cost of Raw Material
      • 4.4 Channel Analysis
        • 4.4.1 Distribution Channel-Under the Epidemic Situation
        • 4.4.2 Distributors

      5 Regional Market Forecast (2021-2027)

      • 5.1 Global Cold Chain for Pharmaceutical Sales and Growth Rate (2021-2027)
      • 5.2 Global Cold Chain for Pharmaceutical Sales Value and Growth Rate (2021-2027)

      6 Cold Chain for Pharmaceutical Competitive Analysis

      • 6.1 United Parcel Service of America
        • 6.1.1 United Parcel Service of America Company Profiles
        • 6.1.2 United Parcel Service of America Product Introduction
        • 6.1.3 United Parcel Service of America Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.1.4 SWOT Analysis
      • 6.2 OOCL Logistics Ltd.
        • 6.2.1 OOCL Logistics Ltd. Company Profiles
        • 6.2.2 OOCL Logistics Ltd. Product Introduction
        • 6.2.3 OOCL Logistics Ltd. Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.2.4 SWOT Analysis
      • 6.3 JWD Infologistics Public Company Ltd
        • 6.3.1 JWD Infologistics Public Company Ltd Company Profiles
        • 6.3.2 JWD Infologistics Public Company Ltd Product Introduction
        • 6.3.3 JWD Infologistics Public Company Ltd Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.3.4 SWOT Analysis
      • 6.4 Nichirei Logistics Group Inc.
        • 6.4.1 Nichirei Logistics Group Inc. Company Profiles
        • 6.4.2 Nichirei Logistics Group Inc. Product Introduction
        • 6.4.3 Nichirei Logistics Group Inc. Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.4.4 SWOT Analysis
      • 6.5 SCG Logistics Management Company Limited
        • 6.5.1 SCG Logistics Management Company Limited Company Profiles
        • 6.5.2 SCG Logistics Management Company Limited Product Introduction
        • 6.5.3 SCG Logistics Management Company Limited Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.5.4 SWOT Analysis
      • 6.6 X2 Logistics Network ( X2 GROUP)
        • 6.6.1 X2 Logistics Network ( X2 GROUP) Company Profiles
        • 6.6.2 X2 Logistics Network ( X2 GROUP) Product Introduction
        • 6.6.3 X2 Logistics Network ( X2 GROUP) Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.6.4 SWOT Analysis
      • 6.7 AIT Worldwide Logistics Inc.
        • 6.7.1 AIT Worldwide Logistics Inc. Company Profiles
        • 6.7.2 AIT Worldwide Logistics Inc. Product Introduction
        • 6.7.3 AIT Worldwide Logistics Inc. Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.7.4 SWOT Analysis
      • 6.8 CWT PTE. LIMITED (CWT International Ltd.)
        • 6.8.1 CWT PTE. LIMITED (CWT International Ltd.) Company Profiles
        • 6.8.2 CWT PTE. LIMITED (CWT International Ltd.) Product Introduction
        • 6.8.3 CWT PTE. LIMITED (CWT International Ltd.) Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.8.4 SWOT Analysis
      • 6.9 SF Express
        • 6.9.1 SF Express Company Profiles
        • 6.9.2 SF Express Product Introduction
        • 6.9.3 SF Express Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.9.4 SWOT Analysis
      • 6.10 CJ Rokin Logistics
        • 6.10.1 CJ Rokin Logistics Company Profiles
        • 6.10.2 CJ Rokin Logistics Product Introduction
        • 6.10.3 CJ Rokin Logistics Cold Chain for Pharmaceutical Production, Revenue (2017-2021)
        • 6.10.4 SWOT Analysis

      7 Conclusion

      Summary

      As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

      Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
      In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
      Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
      Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Cold Chain for Pharmaceutical market in this environment.

      In terms of revenue, this research report indicated that the global Cold Chain for Pharmaceutical market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Cold Chain for Pharmaceutical industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

      The United Parcel Service of America aims at producing XX K Units Cold Chain for Pharmaceutical in 2020, with XX % production to take place in global market, OOCL Logistics Ltd. accounts for a volume share of XX %.

      Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Cold Chain for Pharmaceutical Market by XYZResearch Include
      China
      EU
      USA
      Japan
      India
      Southeast Asia
      South America
      Competitive Analysis; Who are the Major Players in Cold Chain for Pharmaceutical Market?
      United Parcel Service of America
      OOCL Logistics Ltd.
      JWD Infologistics Public Company Ltd
      Nichirei Logistics Group Inc.
      SCG Logistics Management Company Limited
      X2 Logistics Network ( X2 GROUP)
      AIT Worldwide Logistics Inc.
      CWT PTE. LIMITED (CWT International Ltd.)
      SF Express
      CJ Rokin Logistics
      ...
      Major Type of Cold Chain for Pharmaceutical Covered in XYZResearch report:
      Cold Storage
      Cold Chain Transport
      Application Segments Covered in XYZResearch Market
      Chilled
      Frozen
      Application 3

      For any other requirements, please feel free to contact us and we will provide you customized report.


      Summary:
      Get latest Market Research Reports on Cold Chain for Pharmaceutical. Industry analysis & Market Report on Cold Chain for Pharmaceutical is a syndicated market report, published as (Post-pandemic Era)-Global Cold Chain for Pharmaceutical Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027. It is complete Research Study and Industry Analysis of Cold Chain for Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,650.00
      $5,600.00
      2,646.25
      4,060.00
      3,131.70
      4,804.80
      416,976.00
      639,744.00
      274,224.50
      420,728.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report